Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare-Reference-Cited by-同舟云学术

Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare

Published:2018-12-21 Issue:1 Volume:8 Page:94-103
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Sheehan Deirdre F.¹,Criss Steven D.¹^ORCID,Chen Yufan¹,Eckel Andrew¹,Palazzo Lauren¹,Tramontano Angela C.¹^ORCID,Hur Chin¹²,Cipriano Lauren E.³^ORCID,Kong Chung Yin¹⁴^ORCID

Affiliation:

1. Institute for Technology Assessment; Massachusetts General Hospital; Boston Massachusetts

2. Department of Medicine; Harvard Medical School; Boston Massachusetts

3. Ivey Business School; Western University; London Ontario Canada

4. Department of Radiology; Harvard Medical School; Boston Massachusetts

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.1896/fullpdf

Reference25 articles.

1. USCSWG United States Cancer Statistics: 1999-2014 Incidence and Mortality Web-based Report 2017 www.cdc.gov/uscs

2. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

3. Centers for Medicare & Medicaid Services (CMS) Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N) 2015 https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274&NcaName=Screening+for+Lung+Cancer+with+Low+Dose+Computed+Tomography+(LDCT)&MEDCACId=68&IsPopup=y&bc=AAAAAAAAAgAAAA%3d%3d&

4. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N Engl J Med,2011

5. Cost-effectiveness analysis of a capitated patient navigation program for medicare beneficiaries with lung cancer;Shih;Health Serv Res,2016

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical costs of lung cancer by stage, histology and first-line treatment modality in the Netherlands (2012–2021);European Journal of Cancer;2024-09

2. Cost-effectiveness analysis of amivantamab plus chemotherapy for non-small cell lung cancer patients with epidermal growth factor receptor exon 20 insertions in the United States;International Journal of Clinical Pharmacy;2024-07-11

3. Unlocking the Potential of AI in Cancer Therapeutics: Advancements in Treatment Selection, Swift Diagnosis, Risk Assessment, and Prognosis;Current Cancer Therapy Reviews;2024-06-04

4. The Clinical and Economic Implications of Different Treatment Pathways for Patients With Rapidly Recurrent Malignant Pleural Effusion;CHEST;2024-06

5. Uncertainty-aware image classification on 3D CT lung;Computers in Biology and Medicine;2024-04